RA: TNFi is the most preferred therapeutic option for patients with inadequate methotrexate responseJune 11, 2021Rheumatoid Arthritis
Distinct clinical and biomechanical factors could help identify RA patients at risk for fallsJune 11, 2021Rheumatoid Arthritis
RA: Obesity tied to lower odds of remission and more intensive csDMARD exposureJune 11, 2021Rheumatoid Arthritis
MTX+LEF combo shows robust safety profile compared with other therapeutic regimens in RAJune 11, 2021Rheumatoid Arthritis
Rheumatoid meningitis should be considered with or without RA diagnosisJune 11, 2021Rheumatoid Arthritis
Tofacitinib more effective than tocilizumab in bDMARD-naïve patients with methotrexate-refractory RAJune 11, 2021Rheumatoid Arthritis
RA: Three doses of intravenous tranexamic acid more effective than single dose post-TKAJune 11, 2021Rheumatoid Arthritis
RA: ARCTIC REWIND findings do not support csDMARD dose tapering among patients in remissionJune 11, 2021Rheumatoid Arthritis
Rheumatology NewsNovel study links air pollution to increased risk of rheumatoid arthritis flaresJune 8, 2021Rheumatoid Arthritis
Rheumatology NewsPatients with RA on rituximab at risk for worse COVID-19 outcomesJune 8, 2021Rheumatoid ArthritisCOVID-19 Updates
Rheumatology NewsSecondhand smoke in childhood and adulthood linked to increased risk of rheumatoid arthritisJune 5, 2021Rheumatoid Arthritis
Rheumatology NewsGene variant confirmed as strong predictor of lung disease in RAJune 5, 2021Rheumatoid Arthritis
